PA Medical News about Muscle, Skeletal ?-agonists

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders
Current Opinion in Clinical Nutrition & Metabolic Care, 10/27/09

Koopman R et al. – Multiple studies have identified anticachectic effects of beta–agonists and their therapeutic potential for pathologic states when muscle protein hypercatabolism is indicated. Future studies examining beta–agonist administration for muscle wasting conditions need to separate beneficial effects on skeletal muscle from potentially deleterious effects on the heart and cardiovascular system.